These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11430049)

  • 1. Synthesis of the left-hand portion of geldanamycin using an anti glycolate aldol reaction.
    Andrus MB; Meredith EL; Sekhar BB
    Org Lett; 2001 Jan; 3(2):259-62. PubMed ID: 11430049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin: asymmetric glycolate aldol reactions and biological evaluation.
    Andrus MB; Meredith EL; Hicken EJ; Simmons BL; Glancey RR; Ma W
    J Org Chem; 2003 Oct; 68(21):8162-9. PubMed ID: 14535799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions.
    Andrus MB; Meredith EL; Simmons BL; Soma Sekhar BB; Hicken EJ
    Org Lett; 2002 Oct; 4(20):3549-52. PubMed ID: 12323066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective synthesis of the para-quinone region of geldanamycin.
    Andrus MB; Hicken EJ; Meredith EL; Simmons BL; Cannon JF
    Org Lett; 2003 Oct; 5(21):3859-62. PubMed ID: 14535728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of herbimycin A.
    Carter KD; Panek JS
    Org Lett; 2004 Jan; 6(1):55-7. PubMed ID: 14703349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
    Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
    J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of antiproliferative activity of a geldanamycin-Herceptin immunoconjugate.
    Mandler R; Dadachova E; Brechbiel JK; Waldmann TA; Brechbiel MW
    Bioorg Med Chem Lett; 2000 May; 10(10):1025-8. PubMed ID: 10843208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?
    Janin YL
    J Med Chem; 2005 Dec; 48(24):7503-12. PubMed ID: 16302791
    [No Abstract]   [Full Text] [Related]  

  • 9. 19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997.
    Li S; Ni S; Wu L; Li L; Jiang B; Wang H; Sun G; Gan M; Li J; He W; Lin L; Wang Y; Bai S; Si S
    J Nat Prod; 2013 May; 76(5):969-73. PubMed ID: 23656556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the syntheses of benzoquinone ansamycin antibiotics. Syntheses of the C5-C15 subunits of macbecin I, geldanamycin, and herbimycin A.
    Belardi JK; Micalizio GC
    Org Lett; 2006 May; 8(11):2409-12. PubMed ID: 16706538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
    Clevenger RC; Blagg BS
    Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radester, a novel inhibitor of the Hsp90 protein folding machinery.
    Shen G; Blagg BS
    Org Lett; 2005 May; 7(11):2157-60. PubMed ID: 15901158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems.
    Kasuya Y; Lu Z; Kopecková P; Kopecek J
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2089-91. PubMed ID: 11514145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Hsp90 dimerization modulators.
    Chiosis G; Aguirre J; Nicchitta CV
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3529-32. PubMed ID: 16621545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
    Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
    Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of quinolinedione-based geldanamycin analogues.
    Hargreaves R; David CL; Whitesell L; Skibo EB
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3075-8. PubMed ID: 12941337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
    Schnur RC; Corman ML; Gallaschun RJ; Cooper BA; Dee MF; Doty JL; Muzzi ML; DiOrio CI; Barbacci EG; Miller PE
    J Med Chem; 1995 Sep; 38(19):3813-20. PubMed ID: 7562912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of geldanamycin-testosterone hybrids.
    Kuduk SD; Harris TC; Zheng FF; Sepp-Lorenzino L; Ouerfelli Q; Rosen N; Danishefsky SJ
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1303-6. PubMed ID: 10866406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.
    Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP
    Cell; 1997 Apr; 89(2):239-50. PubMed ID: 9108479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.
    Miyata Y
    Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.